Clinical trial
Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease
NCT00316992 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00316992 |
|---|---|
| Title | Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease |
| Official title | A Study of the Safety of Ramelteon in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | Ramelteon and Placebo |
| Enrollment | 25 |
| Start date | Apr 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Apr 21, 2006 |
| Last update posted | Jun 2, 2010 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: